MedPath

AcadeMab Biomedical Inc.

🇹🇼Taiwan
Ownership
Private
Established
2020-01-01
Employees
-
Market Cap
-
Website
https://www.academab.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety of AM-928 Infusion in Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Interventions
First Posted Date
2023-01-18
Last Posted Date
2025-06-18
Lead Sponsor
AcadeMab Biomedical Inc.
Target Recruit Count
38
Registration Number
NCT05687682
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

News

No news found
© Copyright 2025. All Rights Reserved by MedPath